PARP1 Poly(ADP-ribosyl)ates Sox2 to Control Sox2 Protein Levels and FGF4 Expression during Embryonic Stem Cell Differentiation

被引:68
作者
Gao, Furong [1 ,2 ,4 ]
Kwon, Sung Won [3 ]
Zhao, Yingming [3 ]
Jin, Ying [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Sch Med,Inst Hlth Sci,Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai Stem Cell Inst, Shanghai 200025, Peoples R China
[3] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA
[4] Chinese Acad Sci, Grad Sch, Beijing 100000, Peoples R China
基金
中国国家自然科学基金; 国家高技术研究发展计划(863计划);
关键词
NF-KAPPA-B; TRANSCRIPTION FACTOR OCT-4; NANOG GENE-EXPRESSION; CARCINOMA-CELLS; SELF-RENEWAL; POSTTRANSLATIONAL MODIFICATION; REGULATORY ELEMENT; SYNERGISTIC ACTION; MOUSE DEVELOPMENT; ADP-RIBOSYLATION;
D O I
10.1074/jbc.M109.033118
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Transcription factors Oct4 and Sox2 are key players in maintaining the pluripotent state of embryonic stem cells (ESCs). Small changes in their levels disrupt normal expression of their target genes. However, it remains elusive how protein levels of Oct4 and Sox2 and expression of their target genes are precisely controlled in ESCs. Here we identify PARP1, a DNA-binding protein with an NAD(+)-dependent enzymatic activity, as a cofactor of Oct4 and Sox2 to regulate expression of their target gene FGF4. We demonstrate for the first time that PARP1 binds the FGF4 enhancer to positively regulate FGF4 expression. Our data show that PARP1 interacts with and poly(ADP-ribosyl)ates Sox2 directly, which may be a step required for dissociation and degradation of inhibitory Sox2 proteins from the FGF4 enhancer. When PARP1 activity is inhibited or absent, poly(ADP-ribosyl)ation of Sox2 decreases and association of Sox2 with FGF4 enhancers increases, accompanied by an elevated level of Sox2 proteins and reduced expression of FGF4. Significantly, specific knockdown of Sox2 expression by RNA interference can considerably abrogate the inhibitory effect of the poly(ADPribose) polymerase inhibitor on FGF4 expression. Interestingly, PARP1 deficiency does not affect undifferentiated ESCs but compromises cell survival and/or growth when ESCs are induced into differentiation. Addition of FGF4 can partially rescue the phenotypes caused by PARP1 deficiency during ESC differentiation. Taken together, this study uncovers new mechanisms through which Sox2 protein levels and FGF4 expression are dynamically regulated during ESC differentiation and adds a new member to the family of proteins regulating the properties of ESCs.
引用
收藏
页码:22263 / 22273
页数:11
相关论文
共 59 条
[1]
Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the Fibroblast growth factor-4 enhancer [J].
Ambrosetti, DC ;
Schöler, HR ;
Dailey, L ;
Basilico, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (30) :23387-23397
[2]
Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites [J].
Ambrosetti, DC ;
Basilico, C ;
Dailey, L .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) :6321-6329
[3]
Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1 [J].
Amiri, K. I. ;
Ha, H. C. ;
Smulson, M. E. ;
Richmond, A. .
ONCOGENE, 2006, 25 (59) :7714-7722
[4]
Multipotent cell lineages in early mouse development depend on SOX2 function [J].
Avilion, AA ;
Nicolis, SK ;
Pevny, LH ;
Perez, L ;
Vivian, N ;
Lovell-Badge, R .
GENES & DEVELOPMENT, 2003, 17 (01) :126-140
[5]
THE FGF FAMILY OF GROWTH-FACTORS AND ONCOGENES [J].
BASILICO, C ;
MOSCATELLI, D .
ADVANCES IN CANCER RESEARCH, 1992, 59 :115-165
[6]
Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes [J].
Boer, Brian ;
Kopp, Janel ;
Mallanna, Sunil ;
Desler, Michelle ;
Chakravarthy, Harini ;
Wilder, Phillip J. ;
Bernadt, Cory ;
Rizzino, Angie .
NUCLEIC ACIDS RESEARCH, 2007, 35 (06) :1773-1786
[7]
Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells [J].
Boer, Brian ;
Bernadt, Cory T. ;
Desler, Michelle ;
Wilder, Phillip J. ;
Kopp, Janel L. ;
Rizzino, Angie .
JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 208 (01) :97-108
[8]
The origin and efficient derivation of embryonic stem cells in the mouse [J].
Brook, FA ;
Gardner, RL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (11) :5709-5712
[9]
Self-renewal of teratocarcinoma and embryonic stem cells [J].
Chambers, I ;
Smith, A .
ONCOGENE, 2004, 23 (43) :7150-7160
[10]
Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells [J].
Chambers, I ;
Colby, D ;
Robertson, M ;
Nichols, J ;
Lee, S ;
Tweedie, S ;
Smith, A .
CELL, 2003, 113 (05) :643-655